These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 22188737)

  • 21. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
    Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
    Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heparin-induced thrombocytopenia: implictions for cardiologist].
    Mattioli AV
    G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to the diagnosis of heparin-induced thrombocytopenia.
    Warkentin TE
    Chest; 2005 Feb; 127(2 Suppl):35S-45S. PubMed ID: 15706029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond the platelet count: heparin antibodies as independent risk predictors.
    Stribling WK; Slaughter TF; Houle TT; Sane DC
    Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Management of heparin-induced thrombocytopenia].
    Aouizerate P; Guizard M
    Therapie; 2002; 57(6):577-88. PubMed ID: 12666266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombopenias induced by heparin: diagnostic and therapeutic innovations].
    Righini M; de Moerloose P
    Rev Med Suisse Romande; 2001 Apr; 121(4):313-8. PubMed ID: 11400405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by "true" heparin-induced thrombocytopenia.
    Warkentin TE; Moore JC; Vogel S; Sheppard JA; Warkentin NI; Eikelboom JW
    Thromb Haemost; 2012 May; 107(5):998-1000. PubMed ID: 22371139
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia.
    Warkentin TE
    Hematol Oncol Clin North Am; 2007 Aug; 21(4):589-607, v. PubMed ID: 17666280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin-induced thrombocytopenia.
    Greinacher A; Fürll B; Selleng S
    Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.
    Greinacher A; Warkentin TE
    Expert Rev Hematol; 2008 Oct; 1(1):75-85. PubMed ID: 21083008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HITlights: a career perspective on heparin-induced thrombocytopenia.
    Warkentin TE
    Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin-induced thrombocytopenia. New therapeutical options].
    Seculini Patiño CE; Tabares AH
    Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia: current status and diagnostic challenges.
    Otis SA; Zehnder JL
    Am J Hematol; 2010 Sep; 85(9):700-6. PubMed ID: 20665476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin-induced thrombocytopenia: what a vascular surgeon needs to know.
    Dalainas I; Avgerinos ED; Liapis CD
    J Cardiovasc Surg (Torino); 2011 Feb; 52(1):81-8. PubMed ID: 21224814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia: some working hypotheses on pathogenesis, diagnostic strategies and treatment.
    Alberio L
    Curr Opin Hematol; 2008 Sep; 15(5):456-64. PubMed ID: 18695368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.